Gene Therapy for Diabetic Macular Edema

NCT05916391 · clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
18
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Frontera Therapeutics

Collaborators